Education
About Us
Working with TipRanks
Follow Us
Acarix AB (DE:7AC)
:7AC
7AC Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.01 - €0.05
Previous CloseN/A
Volume0.00
Average Volume (3M)66.00
Market Cap
€23.40M
Enterprise ValueN/A
Total Cash (Recent Filing)€53.99M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta0.96
Next Earnings
Aug 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,063,743,800
10 Day Avg. Volume0
30 Day Avg. Volume66
Financial Highlights & Ratios
PEG Ratio-0.17
Price to Book (P/B)3.06
Price to Sales (P/S)0.00
P/FCF Ratio-3.54
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
7AC FAQ
What was Acarix AB’s price range in the past 12 months?
Acarix AB lowest stock price was €0.01 and its highest was €0.05 in the past 12 months.
What is Acarix AB’s market cap?
Acarix AB’s market cap is €23.40M.
When is Acarix AB’s upcoming earnings report date?
Acarix AB’s upcoming earnings report date is Aug 21, 2025 which is in 75 days.
How were Acarix AB’s earnings last quarter?
Acarix AB released its earnings results on May 12, 2025. The company reported -€0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.001.
Is Acarix AB overvalued?
According to Wall Street analysts Acarix AB’s price is currently Overvalued.
Does Acarix AB pay dividends?
Acarix AB does not currently pay dividends.
What is Acarix AB’s EPS estimate?
Acarix AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Acarix AB have?
Acarix AB has 1,063,743,800 shares outstanding.
What happened to Acarix AB’s price movement after its last earnings report?
Acarix AB reported an EPS of -€0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Acarix AB?
Currently, no hedge funds are holding shares in DE:7AC
Company Description
Acarix AB
Acarix AB (publ), a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases in Germany, Sweden, the Middle East, Switzerland, Austria, and internationally. The company offers CADScor System, a non-invasive and ultra-sensitive analytical device for the diagnosis of coronary artery disease. Acarix AB (publ) was founded in 2009 and is headquartered in Malmö, Sweden.
Technical Analysis
SciBase Holding AB
―
SpectraCure AB
―
Integrum AB Class B
―
Q-linea AB
―
BrainCool AB
―